NVCR
NovoCure Ltd

7,381
Mkt Cap
$1.46B
Volume
130,572.00
52W High
$27.32
52W Low
$10.70
PE Ratio
-8.41
NVCR Fundamentals
Price
$14.24
Prev Close
$13.56
Open
$13.66
50D MA
$12.74
Beta
1.40
Avg. Volume
1.68M
EPS (Annual)
-$1.56
P/B
4.45
Rev/Employee
$406,733.87
Loading...
Loading...
News
all
press releases
NovoCure Limited (NASDAQ:NVCR) Short Interest Update
NovoCure Limited (NASDAQ:NVCR - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 8,333,839 shares, an increase of 20.0% from...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Assessing NovoCure: Insights From 4 Financial Analysts
read more...
Benzinga·7d ago
News Placeholder
NovoCure (NASDAQ:NVCR) Receives Neutral Rating from Wedbush
Wedbush reaffirmed a "neutral" rating and issued a $18.00 price objective on shares of NovoCure in a report on Thursday...
MarketBeat·7d ago
News Placeholder
HC Wainwright Has Bullish Estimate for NovoCure Q4 Earnings
NovoCure Limited (NASDAQ:NVCR - Free Report) - Research analysts at HC Wainwright raised their Q4 2025 earnings per share (EPS) estimates for NovoCure in a report issued on Tuesday, January 13th. HC...
MarketBeat·7d ago
News Placeholder
NovoCure Limited (NASDAQ:NVCR) Receives Average Rating of "Hold" from Analysts
NovoCure Limited (NASDAQ:NVCR - Get Free Report) has earned an average recommendation of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One equities...
MarketBeat·7d ago
News Placeholder
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to...
Business Wire·10d ago
News Placeholder
Moderna (MRNA) Soars 10.9%: Is Further Upside Left in the Stock?
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Zacks·15d ago
News Placeholder
Voya Investment Management LLC Sells 64,539,786 Shares of NovoCure Limited $NVCR
Voya Investment Management LLC lowered its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 100.0% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·16d ago
News Placeholder
Novocure (NVCR) Q2 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·30d ago
News Placeholder
Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard...
Business Wire·1mo ago
<
1
2
...
>

Latest NVCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.